NCT01299558
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,753 public trials
646 recruiting studies
Hypersensitivity trial results
NCT01772368
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Teva Investigational Site 10453 Denver, Colorado, United States
- Teva Investigational Site 10452 North Dartmouth, Massachusetts, United States
- Teva Investigational Site 10455 St Louis, Missouri, United States
- Teva Investigational Site 10454 Skillman, New Jersey, United States
NCT01485445
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Berlin, Germany
NCT01673529
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +12 more
- Locations
-
- GSK Investigational Site Cambridge, United Kingdom
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Baltimore, Maryland, United States
NCT00495612
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
NCT02317952
- Conditions
- Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +3 more
- Locations
-
- Clinical Research Center of Alabama Birmingham, Alabama, United States
- Arkansas Children's Hosptial Little Rock, Arkansas, United States
- Pediatric Care Medical Group Huntington Beach, California, United States
- Children's Hospital of Los Angeles Los Angeles, California, United States
NCT01312961
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Investigational Site Number 840047 Anaheim, California, United States
- Investigational Site Number 840046 Long Beach, California, United States
- Investigational Site Number 840032 Los Angeles, California, United States
- Investigational Site Number 840036 Los Angeles, California, United States
NCT00595361
- Conditions
- Asthma, Asthma, Exercise-Induced, Bronchial Diseases, +8 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- University of Wisconsin Madison, Wisconsin, United States
Completed
A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole
NCT01165125
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site London, United Kingdom